Indiana, US-based biopharma bigwig Eli Lilly has doubled its investment to a total of $2 billion at its Limerick, Ireland manufacturing site. The expansion will increase production of biologic active ...

Steve McCloskey , founder and chief executive officer, Nanome McCloskey began his presentation by sharing an artificial-intelligence (AI)–generated image of the future of AI-supplemented drug ...

This special summer issue serves as an “expression platform” for as many different industry voices as we could squeeze in between our front and back covers. To get even more points of view than our ...

HTTPS://WWW.ISTOCKPHOTO.COM It’s no secret that mammalian cell culture is the predominant production system in the biopharmaceutical industry. Microbial expression has been around longer, not least ...

The firms will co-commercialize the products globally, except for MK-6070 in Japan where Merck (known as MSD outside of the US and Canada) will retain the exclusive rights. Merck will also be solely ...

With this issue, we bid a reluctant farewell to our managing editor as she retires. Cheryl and I have known her and appreciated her friendship for 26 years. Her accumulated knowledge of cell and gene ...

This special insert summarizes our well-attended BioProcess Theater at the BIO International Convention in San Diego this past June. Focusing on emerging therapies and technologies enabled us to touch ...

Founded in the middle of 2002, BPI published its first issue in January of 2003. Our 20th-anniversary issue thus takes the form of a state-of-the-early-21st-century industry report. Assembling this ...

November-December 2019 ...

Protein A has made monoclonal antibodies (MAbs) highly manufacturable and easier to develop in laboratories. Its use has enabled purification platform approaches, which have been key elements in ...

Martin Smith, PhD CTO, Pall Corporation Thank you for taking the time to view our supplement, which has been driven by our desire to share actionable knowledge in a convenient format as well as to act ...